This Is MS Multiple Sclerosis Community: Knowledge & Support
Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.
Like LittleLisa, I am in the clinical trial that compare Campath to Rebif. I also had a relaps after about 6 months, but was able to control the relapse with steroids. I had a second infusion one and a half years ago, and am now stabilized. I recently had an MRI of the brain C-spine and T-spine. Not only is there no active disease, scarring from my very first attack has improved.
According to my Neurologist, she believes that Campath is going to be approved by the FDA either later this year or the beginning of next year.
Yes, I am certain that I received Campath. In this trial, it is only compared to Rebif; that is the only other treatment. No one is given placebo. Rebif and Campath are administered differently, so there is no question that I was given Campath.